270 related articles for article (PubMed ID: 19919975)
1. Adenosine A1 receptor antagonists at a fork in the road.
Givertz MM
Circ Heart Fail; 2009 Nov; 2(6):519-22. PubMed ID: 19919975
[No Abstract] [Full Text] [Related]
2. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
3. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.
Dittrich HC; Gupta DK; Hack TC; Dowling T; Callahan J; Thomson S
J Card Fail; 2007 Oct; 13(8):609-17. PubMed ID: 17923351
[TBL] [Abstract][Full Text] [Related]
4. Management of chronic congestive heart failure: Part I--General introduction to treatment.
Kayser SR
Prog Cardiovasc Nurs; 1994; 9(1):39-42. PubMed ID: 8058693
[No Abstract] [Full Text] [Related]
5. [Diastolic heart failure. Pathophysiology, diagnosis and therapy].
von Scheidt W
Med Klin (Munich); 1996 Jan; 91(1):28-35. PubMed ID: 8839198
[No Abstract] [Full Text] [Related]
6. Adenosine1 receptor antagonism: a new therapeutic approach for the treatment of decompensated heart failure.
Shah RH; Frishman WH
Cardiol Rev; 2009; 17(3):125-31. PubMed ID: 19384086
[TBL] [Abstract][Full Text] [Related]
7. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function).
Voors AA; Dittrich HC; Massie BM; DeLucca P; Mansoor GA; Metra M; Cotter G; Weatherley BD; Ponikowski P; Teerlink JR; Cleland JG; O'Connor CM; Givertz MM
J Am Coll Cardiol; 2011 May; 57(19):1899-907. PubMed ID: 21545947
[TBL] [Abstract][Full Text] [Related]
8. Vericiguat (Verquvo) for heart failure.
Med Lett Drugs Ther; 2021 Mar; 63(1619):36-37. PubMed ID: 33755653
[No Abstract] [Full Text] [Related]
9. Vericiguat in worsening heart failure: agonising over, or celebrating, agonism in the VICTORIA trial.
Lang NN; Dobbin SJH; Petrie MC
Cardiovasc Res; 2020 Oct; 116(12):e152-e155. PubMed ID: 32980877
[No Abstract] [Full Text] [Related]
10. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?
Schrier RW
J Am Coll Cardiol; 2006 Jan; 47(1):1-8. PubMed ID: 16386657
[TBL] [Abstract][Full Text] [Related]
11. Rationale, design, and results from RENO-DEFEND 1: a randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure.
Pang PS; Mehra M; Maggioni AP; Filippatos G; Middlebrooks J; Turlapaty P; Kazei D; Gheorghiade M;
Am Heart J; 2011 Jun; 161(6):1012-23.e3. PubMed ID: 21641345
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Drug Development in Heart Failure: Call for Hemodynamically Neutral Therapies.
Vaduganathan M; Butler J; Pitt B; Gheorghiade M
Circ Heart Fail; 2015 Jul; 8(4):826-31. PubMed ID: 26199309
[No Abstract] [Full Text] [Related]
13. [Acute and chronic heart failure--innovations of the last year and their underlying clinical trials].
Ewen S; Böhm M
Dtsch Med Wochenschr; 2014 Nov; 139(45):2294-8. PubMed ID: 25350243
[No Abstract] [Full Text] [Related]
14. [Therapy of acute heart failure].
Blanke H
Internist (Berl); 1993 Oct; 34(10):929-38. PubMed ID: 8225842
[No Abstract] [Full Text] [Related]
15. Drugs for treatment of chronic heart failure.
Treat Guidel Med Lett; 2009 Jul; 7(83):53-6. PubMed ID: 19556942
[No Abstract] [Full Text] [Related]
16. Heart failure management: 25 years of progress.
Sharpe N
N Z Med J; 2001 Feb; 114(1125):23-4. PubMed ID: 11277469
[No Abstract] [Full Text] [Related]
17. Aging and heart failure.
Hixon ME
Prog Cardiovasc Nurs; 1994; 9(1):4-12. PubMed ID: 8058694
[TBL] [Abstract][Full Text] [Related]
18. BG-9928 (Biogen Idec).
Doggrell SA
Curr Opin Investig Drugs; 2005 Sep; 6(9):962-8. PubMed ID: 16187697
[TBL] [Abstract][Full Text] [Related]
19. A1 adenosine receptor antagonists, agonists, and allosteric enhancers.
Kiesman WF; Elzein E; Zablocki J
Handb Exp Pharmacol; 2009; (193):25-58. PubMed ID: 19639278
[TBL] [Abstract][Full Text] [Related]
20. Tonapofylline: a selective adenosine-1 receptor antagonist for the treatment of heart failure.
Ensor CR; Russell SD
Expert Opin Pharmacother; 2010 Oct; 11(14):2405-15. PubMed ID: 20807184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
